10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2021 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
(In Millions) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
Revenues: | |||
Total revenues | $ 25,979 | 25,424 | 23,362 |
Operating expenses: | |||
Cost of sales | 6,454 | 6,159 | 4,356 |
Research and development | 4,819 | 4,207 | 4,116 |
Acquired in-process research and development | 1,505 | 0 | 0 |
Selling, general and administrative | 5,368 | 5,730 | 5,150 |
Other | 194 | 189 | 66 |
Total operating expenses | 18,340 | 16,285 | 13,688 |
Operating income | 7,639 | 9,139 | 9,674 |
Interest expense, net | (1,197) | (1,262) | (1,289) |
Other income, net | 259 | 256 | 753 |
Income before income taxes | 6,701 | 8,133 | 9,138 |
Provision for income taxes | 808 | 869 | 1,296 |
Net income | 5,893 | 7,264 | 7,842 |
Earnings per share: | |||
Basic (in usd per share) | 10.34 | 12.40 | 12.96 |
Diluted (in usd per share) | 10.28 | 12.31 | 12.88 |
Shares used in the calculation of earnings per share: | |||
Basic (in shares) | 570 | 586 | 605 |
Diluted (in shares) | 573 | 590 | 609 |
Product and Service | |||
Product sales | |||
Total revenues | 24,297 | 24,240 | 22,204 |
Other revenues | |||
Total revenues | 1,682 | 1,184 | 1,158 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |